Literature DB >> 6600889

The role of oxidative processes in emphysema.

A Janoff, H Carp, P Laurent, L Raju.   

Abstract

Elastase/elastase inhibitor imbalance in the lung has been implicated in the pathogenesis of pulmonary emphysema. In light of this, it may be significant that the activity of two major elastase inhibitors, alpha 1-proteinase inhibitor (alpha 1-antitrypsin, alpha 1Pi) and bronchial mucous proteinase inhibitor, can be decreased by oxidizing agents. The effect can be observed with ozone, substances present in cigarette smoke, and oxygen metabolites generated by lung macrophages as well as peroxidative systems released by other phagocytic cells. Thus alpha 1Pi recovered from lung washings of cigarette smokers has only half the predicted normal activity per mg inhibitor and contains 4 moles of methionine sulfoxide (oxidized methionine) per mole of inactive inhibitor. By contrast, alpha 1Pi purified from nonsmokers' lung washings is fully active and contains only native methionine. At the same time, lung washes from some smokers show significantly greater hydrolytic activity against a specific synthetic elastase substrate than do lung washes of nonsmokers. These findings suggest that some smokers may develop an acquired imbalance between elastase and elastase inhibitor in their lungs, favoring activity of the enzyme. In addition to the potential effect of cigarette smoking on lung elastase/elastase inhibitor balance, smoking also may interfere with elastin repair mechanisms. Specifically, acidic water-soluble gas phase components of cigarette smoke prevent synthesis of desmosine cross-links during elastinogenesis in vitro. This report will attempt to correlate the foregoing information on biochemical changes in the lung induced by cigarette smoking with the development of emphysema in the smoker.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600889     DOI: 10.1164/arrd.1983.127.2P2.S31

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  Raised serum concentrations of pancreatic enzymes in cigarette smokers.

Authors:  M A Dubick; C N Conteas; H T Billy; A P Majumdar; M C Geokas
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

Review 2.  alpha-1-Antitrypsin and the pathogenesis of emphysema.

Authors:  R A Stockley
Journal:  Lung       Date:  1987       Impact factor: 2.584

3.  Acute effect of smoking on superoxide production by pulmonary alveolar macrophages.

Authors:  A M Richter; R T Abboud; S S Johal; T A Fera
Journal:  Lung       Date:  1986       Impact factor: 2.584

4.  Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity.

Authors:  E R Pacht; H Kaseki; J R Mohammed; D G Cornwell; W B Davis
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 5.  The alveolar macrophage.

Authors:  R M du Bois
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

6.  Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters.

Authors:  R C Kao; N G Wehner; K M Skubitz; B H Gray; J R Hoidal
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

7.  Ascorbate and cysteine-mediated selective neutralisation of extracellular oxidants during N-formyl peptide activation of human phagocytes.

Authors:  R Anderson; P T Lukey; A J Theron; U Dippenaar
Journal:  Agents Actions       Date:  1987-02

8.  Characterization of the methionine sulfoxide reductases of Schistosoma mansoni.

Authors:  Tolulope T Oke; Jackob Moskovitz; David L Williams
Journal:  J Parasitol       Date:  2009-12       Impact factor: 1.276

9.  Reactive oxygen metabolites can be used to differentiate malignant and non-malignant pleural efffusions.

Authors:  Ufuk Cobanoglu; Fuat Sayir; Duygu Mergan
Journal:  Ann Thorac Med       Date:  2010-07       Impact factor: 2.219

Review 10.  alpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiency.

Authors:  R A Sandhaus
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.